A generalized experimental investigation of hot gas recirculation and ingestion for jet VTOL aircraft

Jet VTOL aircraft inlet temperature rise and induced recirculating flow pattern

Constructing Integrable Third Order Systems:The Gambier Approach

We present a systematic construction of integrable third order systems based on the coupling of an integrable second order equation and a Riccati equation. This approach is the extension of the Gambier method that led to the equation that bears his name. Our study is carried through for both continuous and discrete systems. In both cases the investigation is based on the study of the singularities of the system (the Painlev\'e method for ODE's and the singularity confinement method for mappings).Comment: 14 pages, TEX FIL

Recent Decisions

Comments on recent decisions by Edward J. Flattery, John E. Cosgrove, Thomas Broden, Richard H. Keen, and Ralph L. Fenderson, Jr

Contributors to the January Issue/Notes

Notes by John H. Merryman, John E. Cosgrove, Edward J. Flattery, James D. Sullivan, Lawrence Turner, John O\u27Rorke, Thomas Broden, George S. Stratigos, Richard H. Keen, and J. Barrett Guthrie

Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder.

BACKGROUND:Only 40-60% of patients with generalized anxiety disorder experience long-lasting improvement with gold standard psychosocial interventions. Identifying neurobehavioral factors that predict treatment success might provide specific targets for more individualized interventions, fostering more optimal outcomes and bringing us closer to the goal of "personalized medicine." Research suggests that reward and threat processing (approach/avoidance behavior) and cognitive control may be important for understanding anxiety and comorbid depressive disorders and may have relevance to treatment outcomes. This study was designed to determine whether approach-avoidance behaviors and associated neural responses moderate treatment response to exposure-based versus behavioral activation therapy for generalized anxiety disorder. METHODS/DESIGN:We are conducting a randomized controlled trial involving two 10-week group-based interventions: exposure-based therapy or behavioral activation therapy. These interventions focus on specific and unique aspects of threat and reward processing, respectively. Prior to and after treatment, participants are interviewed and undergo behavioral, biomarker, and neuroimaging assessments, with a focus on approach and avoidance processing and decision-making. Primary analyses will use mixed models to examine whether hypothesized approach, avoidance, and conflict arbitration behaviors and associated neural responses at baseline moderate symptom change with treatment, as assessed using the Generalized Anxiety Disorder-7 item scale. Exploratory analyses will examine additional potential treatment moderators and use data reduction and machine learning methods. DISCUSSION:This protocol provides a framework for how studies may be designed to move the field toward neuroscience-informed and personalized psychosocial treatments. The results of this trial will have implications for approach-avoidance processing in generalized anxiety disorder, relationships between levels of analysis (i.e., behavioral, neural), and predictors of behavioral therapy outcome. TRIAL REGISTRATION:The study was retrospectively registered within 21 days of first participant enrollment in accordance with FDAAA 801 with ClinicalTrials.gov, NCT02807480. Registered on June 21, 2016, before results

The American Psychiatric Association’s Guideline for Major Depressive Disorder: A Commentary

The American Psychiatric Association (APA) published a new guideline for Major Depressive Disorder (MDD) which will undoubtedly be used by many practitioners to guide clinical decision-making. In fact, it is non-psychiatrist clinicians who prescribe the majority of antidepressants (AD). We review the APA’s most recent guideline on MDD and report on our observations

General-relativistic Model of Magnetically Driven Jet

The general scheme for the construction of the general-relativistic model of the magnetically driven jet is suggested. The method is based on the usage of the 3+1 MHD formalism. It is shown that the critical points of the flow and the explicit radial behavior of the physical variables may be derived through the jet ``profile function."Comment: 12 pages, LaTex, no figure

Investigation of a lattice Boltzmann model with a variable speed of sound

A lattice Boltzmann model is considered in which the speed of sound can be varied independently of the other parameters. The range over which the speed of sound can be varied is investigated and good agreement is found between simulations and theory. The onset of nonlinear effects due to variations in the speed of sound is also investigated and good agreement is again found with theory. It is also shown that the fluid viscosity is not altered by changing the speed of sound

Dynamic Informed Consent Processes Vital for Treatment with Antidepressants

Advances in technology and transparency have greatly accelerated the ability of clinicians to remain current with regards to being informed and informing patients about the risk/benefit ratio when considering antidepressant medication. In spite of this, the current climate of pharmaceutical industry influence on medical practice does much to hinder informed consent processes. Recent findings of previously unknown and potentially dangerous adverse effects of the second- and third-generation classes of antidepressants underscore the importance of enhancing the practice of informed consent. After considering the concept of informed consent as it has evolved over time, the authors summarize some of the newer side effects associated with second- and third-generation antidepressants and then move on to describe impediments in the way of achieving adequate informed consent at the clinical encounter. Among these impediments, the authors discuss the impact of industry influence, cognitive bias in decision-making, and time constraints. These obstacles and the notion that modern antidepressants are not as safe as once thought offer an opportunity to revisit the process of informed consent. A dynamic concept of informed consent is proposed with the acknowledgement that a mere listing of side effects or pro forma approach to informed consent is inadequate, and that a deep and ongoing conversation with patients will more likely result in patient empowerment and a strengthening of the therapeutic alliance. This process is analogized to an “n=1” approach where patients’ idiosyncratic responses to second- and third-generation antidepressants can be used to update prior beliefs based on large-scale trials and allow patient and doctor to shoulder the burden of uncertainty together, thereby enhancing placebo and minimizing nocebo response and leading to more optimal treatment outcomes